CO4970800A1 - Forma termodinamicamente estable del acido (r)-3(((4-fluoro- fenil) sulfonil)amino)-1,2,3,4-tetrahidro-9h-carbazo-9-pro- panoico (ramatroban) - Google Patents

Forma termodinamicamente estable del acido (r)-3(((4-fluoro- fenil) sulfonil)amino)-1,2,3,4-tetrahidro-9h-carbazo-9-pro- panoico (ramatroban)

Info

Publication number
CO4970800A1
CO4970800A1 CO98076459A CO98076459A CO4970800A1 CO 4970800 A1 CO4970800 A1 CO 4970800A1 CO 98076459 A CO98076459 A CO 98076459A CO 98076459 A CO98076459 A CO 98076459A CO 4970800 A1 CO4970800 A1 CO 4970800A1
Authority
CO
Colombia
Prior art keywords
ramatroban
thermodynamically stable
panoico
tetrahidro
sulfonil
Prior art date
Application number
CO98076459A
Other languages
English (en)
Spanish (es)
Inventor
Alfons Grunenberg
Wahl Karl Heinz
Voges Klaus Peter
Original Assignee
Bayer Yakuhin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Yakuhin Ltd filed Critical Bayer Yakuhin Ltd
Publication of CO4970800A1 publication Critical patent/CO4970800A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
CO98076459A 1997-12-24 1998-12-23 Forma termodinamicamente estable del acido (r)-3(((4-fluoro- fenil) sulfonil)amino)-1,2,3,4-tetrahidro-9h-carbazo-9-pro- panoico (ramatroban) CO4970800A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19757983A DE19757983A1 (de) 1997-12-24 1997-12-24 Thermodynamisch stabile Form von (r)-3[[(4-Fluorophenyl)sulfonyl]amino]-1,2,3,4-tetrahydro-9H-carbazol-0-propansäure (Ramatroban)

Publications (1)

Publication Number Publication Date
CO4970800A1 true CO4970800A1 (es) 2000-11-07

Family

ID=7853457

Family Applications (1)

Application Number Title Priority Date Filing Date
CO98076459A CO4970800A1 (es) 1997-12-24 1998-12-23 Forma termodinamicamente estable del acido (r)-3(((4-fluoro- fenil) sulfonil)amino)-1,2,3,4-tetrahidro-9h-carbazo-9-pro- panoico (ramatroban)

Country Status (36)

Country Link
US (1) US6362214B1 (enExample)
EP (1) EP1051398B1 (enExample)
JP (2) JP3817668B2 (enExample)
KR (1) KR100586350B1 (enExample)
CN (1) CN1140510C (enExample)
AR (1) AR013803A1 (enExample)
AT (1) ATE263152T1 (enExample)
AU (1) AU744242B2 (enExample)
BG (1) BG65024B1 (enExample)
BR (1) BR9814496A (enExample)
CA (1) CA2313230A1 (enExample)
CO (1) CO4970800A1 (enExample)
DE (2) DE19757983A1 (enExample)
DK (1) DK1051398T3 (enExample)
ES (1) ES2218874T3 (enExample)
GT (1) GT199800198A (enExample)
HN (1) HN1998000186A (enExample)
HU (1) HUP0004432A3 (enExample)
ID (1) ID25446A (enExample)
IL (1) IL136278A (enExample)
IN (1) IN192932B (enExample)
MY (1) MY116312A (enExample)
NO (1) NO316618B1 (enExample)
NZ (1) NZ504741A (enExample)
PE (1) PE20000115A1 (enExample)
PL (1) PL341359A1 (enExample)
PT (1) PT1051398E (enExample)
RU (1) RU2220137C2 (enExample)
SI (1) SI1051398T1 (enExample)
SK (1) SK285109B6 (enExample)
TR (1) TR200001936T2 (enExample)
TW (1) TW552258B (enExample)
UA (1) UA66832C2 (enExample)
UY (2) UY25324A1 (enExample)
WO (1) WO1999033803A1 (enExample)
ZA (1) ZA9811817B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100168137A1 (en) * 2006-12-20 2010-07-01 Johan Raud Combination for use in the treatment of inflammatory disorders
WO2008087371A1 (en) * 2007-01-16 2008-07-24 Cardoz Ab New combination for use in the treatment of inflammatory disorders
WO2009007674A2 (en) * 2007-07-11 2009-01-15 Cardoz Ab Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and ramatroban or seratrodast
WO2011115069A1 (ja) * 2010-03-19 2011-09-22 第一三共株式会社 結晶の網羅的探索
CN103054857A (zh) * 2012-12-30 2013-04-24 北京阜康仁生物制药科技有限公司 一种以雷马曲班为活性成分的固体制剂
JP6770522B2 (ja) 2015-02-13 2020-10-14 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 全身性エリテマトーデスを予防し、及び／又は、治療するためのｐｔｇｄｒ−１及び／又はｐｔｇｄｒ−２アンタゴニスト

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1557665A (en) * 1975-12-10 1979-12-12 Ici Ltd Process for the manufacture of a carboxyalkylamino anthraquinone compounds
US4616028A (en) * 1985-04-22 1986-10-07 American Home Products Corporation Substituted 2,3,4,9-tetrahydro-1H-carbazole-1-acetic acid derivatives, compositions and use
CN1015711B (zh) 1986-02-21 1992-03-04 拜尔公司 制备环烷并[1，2-b]吲哚-磺酰胺类化合物的方法
DE3631824A1 (de) 1986-02-21 1988-03-31 Bayer Ag Cycloalkano(1.2-b)indol-sulfonamide
GB8924392D0 (en) * 1989-10-30 1989-12-20 Bayer Ag Substituted cycloalkano/b/dihydroindole-and-indolesulphonamides
DE19506739A1 (de) 1995-02-27 1996-08-29 Bayer Ag [3-Amino]-tetrahydrocarbazol-propansäureester

Also Published As

Publication number Publication date
IL136278A (en) 2005-03-20
US6362214B1 (en) 2002-03-26
TW552258B (en) 2003-09-11
TR200001936T2 (tr) 2001-01-22
UY25324A1 (es) 2000-12-29
IL136278A0 (en) 2001-05-20
MY116312A (en) 2003-12-31
JP2006151977A (ja) 2006-06-15
EP1051398B1 (en) 2004-03-31
CN1282320A (zh) 2001-01-31
IN192932B (enExample) 2004-06-12
NZ504741A (en) 2002-10-25
SK9752000A3 (en) 2001-02-12
NO316618B1 (no) 2004-03-08
UY25575A1 (es) 1999-11-17
EP1051398A1 (en) 2000-11-15
AU744242B2 (en) 2002-02-21
HN1998000186A (es) 1999-11-03
SI1051398T1 (en) 2004-08-31
UA66832C2 (uk) 2004-06-15
KR20010033529A (ko) 2001-04-25
BG104554A (en) 2001-05-31
DE19757983A1 (de) 1999-07-01
PL341359A1 (en) 2001-04-09
NO20003217L (no) 2000-06-21
WO1999033803A1 (en) 1999-07-08
DK1051398T3 (da) 2004-07-19
PT1051398E (pt) 2004-07-30
HUP0004432A3 (en) 2002-10-28
BR9814496A (pt) 2000-10-10
GT199800198A (es) 1998-12-15
KR100586350B1 (ko) 2006-06-07
SK285109B6 (sk) 2006-06-01
NO20003217D0 (no) 2000-06-21
ATE263152T1 (de) 2004-04-15
JP3817668B2 (ja) 2006-09-06
HUP0004432A2 (hu) 2001-06-28
DE69822882D1 (en) 2004-05-06
JP2001527067A (ja) 2001-12-25
AU1687499A (en) 1999-07-19
JP4411269B2 (ja) 2010-02-10
CN1140510C (zh) 2004-03-03
HK1034517A1 (en) 2001-10-26
BG65024B1 (bg) 2006-12-29
DE69822882T2 (de) 2005-02-03
PE20000115A1 (es) 2000-03-26
ES2218874T3 (es) 2004-11-16
CA2313230A1 (en) 1999-07-08
ID25446A (id) 2000-10-05
ZA9811817B (en) 1999-06-29
AR013803A1 (es) 2001-01-10
RU2220137C2 (ru) 2003-12-27

Similar Documents

Publication Publication Date Title
RU2001118266A (ru) Стабилизация макролидов
CO5650226A2 (es) Forma cristalina del agonista del receptor adrenergico beta
CA2632585A1 (en) Novel modifications to 2-amino-4-(4-fluorobenzylamino)-1-ethoxycarbonyl-aminobenzene and processes for preparing said compound
BG106786A (en) Process for the preparation of amorphous atorvastatin
IL166768A (en) 2-oxo-1-pyrrolidine derivatives and a process for their preparation
ATE329891T1 (de) Kristallisierung von materialien aus wässerigen lösungen
TR200201146T2 (tr) Sertralin hidrokorid polimorfik formları.
AR044029A2 (es) Ritonavir amorfo, procesos para su preparacion y procesos para la preparacion de la forma polimorfa cristalina i de ritonavir sustancialmente pura
AR024494A1 (es) Proceso para la preparacion de derivados de ciclopentano sustituido y novedosas estructuras cristalinas de los mismos
IL164742A0 (en) Process for prepating a pharmaceutically active compound (granisetron)
MY126071A (en) Crystalline form ii of cabergoline.
ES8800164A1 (es) Un procedimiento para preparar derivados de imidazolidina
MX167808B (es) Metodo para separar hidrocloruro de l-cisteina munhidratado
ES2333537T3 (es) Procedimiento de preparacion de carvedilol y sus enantiomeros.
KR960703936A (ko) 4"-데옥시-4"-에피-메틸아미노 에버멕틴 B1a/B1b 벤조산 염의 열역학적으로 안정한 결정체형 및 이의 제조방법(Thermodynamically stable crystal form of 4"-deoxy-4"-epi-methylamino avermectin B1a/B1b benzoic acid salt and process for its preparation)
EP1069115B1 (en) Process for producing oxazolidin-2-one derivatives
ES8704162A1 (es) Un procedimiento para preparar oxadiazolil-1,4-dihidropiri- dinas y sus compuestos analogos
MX172181B (es) Procedimiento para la preparacion de derivados de carbamato
PE20020339A1 (es) Derivados de pirrolidin como inhibidores de las metaloproteasas
BG104554A (en) Thermodynamically stable form of (r)-3-[(-4-fluorophenyl) sulphonyl]amino 1,2,3,4-tetrahydro-9h-carbazole-9-propanoic acid (ramatroban)
RU2000119741A (ru) Термодинамически устойчивая форма (r)-3-[[(4-фторфенил)-сульфонил]амино]-1,2,3,4-тетрагидро-9н-карбазол-9-пр опановой кислоты (раматробана)
ES2130399T3 (es) Un procedimiento para la preparacion de una modificacion gamma cristalina fisicamente estable de para-aminobencenosulfonamida.
PE27799A1 (es) Formulaciones y formas polimorficas de desferrioxamina y su preparacion
FI103120B1 (fi) Menetelmä laktitolin kiteyttämiseksi
HU886767D0 (en) Process for the preparation of new 20,21-dinor-eburnamenine derivatives, new intermediates thereof, as well as pharmaceutical compositions containing said compounds as active ingredients